Cargando…

Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?

Detalles Bibliográficos
Autor principal:	El-Matary, Wael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802399/ https://www.ncbi.nlm.nih.gov/pubmed/36776651 http://dx.doi.org/10.1093/crocol/otab033

Ejemplares similares

Oral Bran in Patients With Quiescent Ulcerative Colitis: Another Piece in the Diet Puzzle
por: El-Matary, Wael
Publicado: (2020)

Addressing Mental Health in Persons with IBD
por: Bernstein, Charles N
Publicado: (2018)

Health service utilization in IBD: comparison of self-report and administrative data
por: Longobardi, Teresa, et al.
Publicado: (2011)

Personalized management of IBD; is there any practical approach?
por: Norouzinia, Mohsen, et al.
Publicado: (2015)

Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2021)

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Present and Future of Utilizing Healthcare Data
por: Choi, In Young
Publicado: (2023)

IBD in the Time of COVID19
por: Moss, Alan, et al.
Publicado: (2020)

IBD in the elderly - beware of pitfalls!
por: Sharip, Mohmmed T., et al.
Publicado: (2023)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes
por: Hurtado-Lorenzo, Andrés, et al.
Publicado: (2021)

Biomarkers in IBD: What to Utilize for the Diagnosis?
por: D’Incà, Renata, et al.
Publicado: (2023)

Epidemiology and Natural History of IBD in the Paediatric Age
por: Guariso, Graziella, et al.
Publicado: (2014)

“Diet in the Etiopathogenesis of IBD: Is There A Culinary Culprit?”
por: Issokson, Kelly
Publicado: (2020)

Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
por: Horst, Sara
Publicado: (2021)

Impact of Different Nutrition Strategies on Patients with Inflammatory Bowel Disease (IBD)
por: Papadimitriou, Konstantinos, et al.
Publicado: (2023)

JAK Inhibitors: Back to Small Molecules for the Treatment of IBD
por: Panés, Julian, et al.
Publicado: (2020)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Using IBD-REFER: A Substitute for Clinical Judgement?
por: Dueker, Jeffrey M, et al.
Publicado: (2020)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
por: Buderus, Stephan, et al.
Publicado: (2015)

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet
por: Kumar, Aditi, et al.
Publicado: (2022)

Healthcare utilization trends in lumbar disc replacement: population-based administrative data
por: Johnson, Ana P., et al.
Publicado: (2022)

Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
por: Herrera-Gómez, Francisco, et al.
Publicado: (2021)

Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?
por: Gomollón, Fernando, et al.
Publicado: (2021)

Validity of Self-reported Healthcare Utilization Data in the Community Health Survey in Korea
por: Rim, Hwayoung, et al.
Publicado: (2011)

Self-Report of Healthcare Utilization among Community-Dwelling Older Persons: A Prospective Cohort Study
por: van Dalen, Marlies T., et al.
Publicado: (2014)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
por: Proietti, E, et al.
Publicado: (2021)

Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective
por: El-Matary, Wael, et al.
Publicado: (2018)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Zooming in on Inflammatory Bowel Disease: Microbial and Proteomic Features Associated With IBD in Colonic Microenvironments
por: Tamburini, Sabrina, et al.
Publicado: (2016)

Quality improvement in healthcare: the need for valid, reliable and efficient methods and indicators
por: Islam, Mohaimenul, et al.
Publicado: (2019)

The Reliability of Patient Self-reported Utilization in an Inflammatory Bowel Diseases Learning Health System
por: van Deen, Welmoed K, et al.
Publicado: (2021)

T-Cell Specificity Matters in IBD: Impaired IL10 Production Revealed by OmpC-Tetramers
por: Cook, Laura, et al.
Publicado: (2020)

Celiac Disease Presenting as Fever of Unknown Origin
por: Cooney, Megan J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c2g8qs88dghirlaerqdln8mmo1